Natco Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted a routine quarterly compliance certificate to BSE and NSE for the quarter ended December 31, 2025. The certificate was issued by its Registrar and Share Transfer Agent, Venture Capital and Corporate Investments Private Limited. It confirms that all share certificates received for dematerialization were cancelled and the depository records (NSDL and CDSL) were updated as the registered owner within 15 days. The company has also reported the details of these securities to the stock exchanges. This is a standard procedural filing and not a corporate action.
No impact on shareholders or stock price. This is a routine regulatory compliance filing required every quarter, with no change in shareholding structure or business operations.